ABSTRACT-Effects of an adenosine Al-receptor agonist and antagonist were determined in pertussis toxin (IAP)-treated and non-treated rats. (-)-N6-(2-phenylisopropyl) adenosine, an adenosine A,-agonist, re duced the urine volume and sodium excretion without decreasing the glomerular filtration rate at 0.1 mg/kg (p.o.) in both IAP-treated and non-treated rats. Diuretic effects of KW-3902 (8-(noradamantan-3-yl)-1,3 dipropylxanthine) and 8-cyclopentyl-l,3-dipropylxanthine, adenosine A,-receptor antagonists, were not affected by pretreatment with IAP. These results suggest that endogenous adenosine may induce antidiuretic effects by accelerating the reabsorption of water and sodium at tubular sites via an IAP-insensitive mechanism, and that the diuretic effects of the adenosine A,-receptor antagonist may result from inhibiting this action of endogenous adenosine.
It is reported that activation of adenosine A,-receptors produces an antidiuretic effect by decreasing the glomeru lar filtration rate (GFR), resulting from the constriction of the afferent arterioles and mesangial cells in the kidney (1) (2) (3) (4) . Most of the adenosine A,-receptors are coupled to various effectors through GTP binding inhibitory pro teins (G; proteins), and most of the effects of adenosine A,-agonists are abolished by treatment of animals or cells with pertussis toxin (IAP). For example, inhibition of re nin secretion and cAMP accumulation in rat renal corti cal slices (5) and increase of cytosolic free calcium in rab bit cortical collecting tubule cells induced by adenosine A,-agonists (6) are abolished by IAP pretreatment of the animals or cells. However, we reported previously that the diuretic effect of KW-3902 (8-(noradamantan-3-yl)-1,3 dipropylxanthine), a selective and potent adenosine A, receptor antagonist, persists even in IAP-treated rats (7) .
In the present study, we determined whether the anti diuretic effects of (-)-1V6-(2-phenylisopropyl) adenosine (R-PIA), an adenosine A,-agonist, are always accom panied with a decrease of creatinine clearance (CORE), an index of GFR. Furthermore, whether the antidiuretic effect of R-PIA is abolished by IAP pretreatment was also inves tigated. If the antidiuretic effect of endogenous adenosine is mediated via an IAP-sensitive mechanism, the diuretic effect of an adenosine A,-receptor antagonist must dis appear in IAP-treated rats. To test this hypothesis, the diuretic effects of KW-3902 and 8-cyclopentyl-1,3 dipropylxanthine (DPCPX), which is an established adenosine A,-receptor antagonist (8-10), was also stud ied in IAP-treated rats.
Male Wistar rats (Shizuoka Laboratory Animal Cen ter, Inc., Hamamatsu) were used in the present studies. They were kept at 22C and on a 12 hr light-dark cycle. They had free access to tap water and commercial chow. Some rats were injected with IAP (10 pg/kg, i.v.) 7 days prior to the experiment. This dose of IAP totally abolished the bradycardic response to 5'-N-ethylcarbox amidoadenosine via adenosine A,-receptors (7). KW-3902 and DPCPX were synthesized at Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd. IAP and R-PIA were purchased from Sigma Chemical Co., Ltd. (St. Louis, MO, USA).
R-PIA (0.1 or 1 mg/kg, p.o.) was administered to IAP-treated rats and non-treated rats with or without co-administration of KW-3902 (0.1 mg/kg, p.o.), and urine was collected for 4 hr. KW-3902 antagonizes the 5'-N-ethylcarboxamidoadenosine-induced bradycardic response which is thought to be mediated via adenosine A,-receptors (7). Soon after the urine collection, blood was collected from the abdominal aorta under ether anesthesia and centrifuged (3000 rpm, 10 min, 41C) to obtain the serum. R-PIA and KW-3902 were suspended in saline containing 0.5 mg/ml Tween 80 and orally ad ministered to rats at a volume of 25 ml/kg. To the rats in the control groups, only the solvent was orally ad ministered at the same volume. After urine volume was measured, the concentration of sodium was determined by flame photometry (775-A; Hitachi, Ltd., Tokyo), from which sodium excretion was calculated. Concentra tions of creatinine (CRE) in the urine and serum were de termined by an autoanalyzer (AU510; Olympus, Tokyo), from which CCRE was calculated. Table 1 shows the diuretic effects of KW-3902 and anti diuretic effects of R-PIA in IAP-treated and non-treated rats. KW-3902 caused a significant diuresis and natriure sis with no change in CCRE in both IAP-treated and non treated rats. In IAP non-treated rats, R-PIA at a low dose of 0.1 mg/kg (p.o.) induced significant decreases of urine volume and sodium excretion without any influence on CCRE. At a high dose of 1 mg/kg, the antidiuretic effect of R-PIA was accompanied with a decrease of CCRE. These results suggest that the adenosine A,-agonist causes anti diuretic effects not only by the decrease of GFR resulting from the constriction of the afferent arterioles and mesan gial cells (1 -4) but also by the acceleration of reabsorp tion of water and sodium at tubular sites. Similar effects of R-PIA were also observed in IAP-treated rats, suggest ing that the renal effect of the adenosine A,-agonist are mediated via an IAP-insensitive mechanism. These effects of R-PIA were completely abolished by the co-administra tion of KW-3902. Table 1 .
Antidiuretic effects of R-PIA and the influence of KW-3902 in IAP-treated and non-treated rats Table 2 . Diuretic effects of KW-3902 and DPCPX in IAP-treated and non-treated rats KW-3902 (0.1 mg/kg, p.o.) or DPCPX (1 mg/kg, p.o.) was administered to IAP-treated rats and non-treated rats. Drugs were suspended in saline containing 0.5 mg/ml Tween 80, and the suspensions were orally ad ministered to rats at a volume 25 ml/kg. Urine was collect ed for 4 hr, and the urine volume and concentrations of sodium and potassium were determined.
As shown in Table 2 , the diuretic effect of KW-3902 was not abolished by IAP treatment and persisted to an extent similar to that in IAP non-treated rats. Further more, DPCPX, which is another adenosine A,-receptor antagonist, induced diuretic effects in both IAP-treated rats and non-treated rats, like KW-3902. These results support the notion that the diuretic effect of the adeno sine A,-receptor antagonist is exhibited through an IAP insensitive mechanism (7).
We reported previously that the diuretic effect of KW 3902 is produced by inhibiting reabsorption of water and sodium at tubular sites but not by affecting renal hemodynamics in normal rats (7, 11) . The results from the previous study and the present one suggest that endogenous adenosine may induce antidiuretic effects by accelerating reabsorption of water and sodium at tubular sites via an IAP-insensitive mechanism, and that the di uretic effects of the adenosine A,-receptor antagonist may result from inhibiting this action of endogenous adeno sine. 
